Table I.
Group | Control group (n=50) | Treatment group (n=40) | t/χ2 | P-value |
---|---|---|---|---|
Male/female | 28/22 | 23/17 | 0.020 | 0.887 |
Age (years) | 53.6±12.4 | 55.7±13.6 | 0.127 | 0.763 |
Maximum tumor diameter (cm) | 2.5±1.2 | 2.6±1.4 | 0.223 | 0.635 |
No. of tumors | 1.5±0.5 | 1.4±0.3 | 0.152 | 0.732 |
AFP (µg/l) | 562.4±56.7 | 594.7±62.3 | 0.327 | 0.649 |
ALT (U/l) | 65.7±12.3 | 64.8±13.5 | 0.217 | 0.658 |
Overall bilirubin (µmol/l) | 19.2±4.3 | 21.3±4.5 | 0.232 | 0.612 |
Albumin (g/l) | 42.5±3.6 | 41.7±3.8 | 0.128 | 0.745 |
AFP, alpha-fetoprotein; ALT, alanine aminotransferase.